Extract notice to the Minister

Lupin-Letermovir

Common name / Subject : létermovir
Name of the manufacturer : Lupin
Form : Co.
Dosage : 240 mg, 480 mg

Indication :

INESSS' Recommendation
Inscription - Sous conditions

Minister's decisions
Inscrire sur les listes des médicaments - Médicament d'exception (2026-07-30)

Evaluation published on July 28, 2026

Subscribe to our newsletter now

Subscription